|
0 members (),
639
guests, and
28
robots. |
Key:
Admin,
Global Mod,
Mod
|
S |
M |
T |
W |
T |
F |
S |
|
|
|
1
|
2
|
3
|
4
|
5
|
6
|
7
|
8
|
9
|
10
|
11
|
12
|
13
|
14
|
15
|
16
|
17
|
18
|
19
|
20
|
21
|
22
|
23
|
24
|
25
|
26
|
27
|
28
|
29
|
30
|
31
|
|
There are no members with birthdays on this day. |
|
|
SPC MD 789
by Webmaster - Wed 15 May 2024 09:00:AM
|
|
|
|
|
|
|
|
#462097
Thu 19 Jul 2018 11:56:PM
|
Joined: Feb 2001
Posts: 381,903
Launch Director
|
OP
Launch Director
Joined: Feb 2001
Posts: 381,903 |
Among individuals with autosomal dominant polycystic kidney disease, those who were treated with tolvaptan for up to 11 years had a slower rate of kidney function decline compared with historical controls. Annualized kidney function decline rates of tolvaptan-treated patients did not change during follow-up. Source: Long-term effectiveness of therapy for common cause of kidney failure
David Cottle
UBB Owner & Administrator
|
|
CMS The Best Conveyancing solicitors conveyancing quotes throughout the UK
For any webhosting enquiries please email webmaster@aus-city.com
|
Forums60
Topics686,583
Posts721,194
Members2,957
|
Most Online3,142 Jan 16th, 2023
|
|
|
|
Copyright 1996 - 2023 by David Cottle. Designed by David Bate Jr. All Rights Reserved.
By using this forum, the user agrees not to transfer any data or technical information received under the agreement, to any other entity without the express approval of the AUS-CITY Forum Admins and/or authors of individual posts (Forum Admins and DoD/USSPACECOM for the analysis of satellite tracking data).
Two-line elements (TLE) and all other satellite data presented and distributed via this forum and e-mail lists of AUS-CITY are distributed with permission from DoD/USSTRATCOM.
Reprise Hosting
|
|